Two doors for every remedy
When the person prescribing the gemstone profits from the gemstone, the prescription is worth nothing. Here is how we removed the incentive without removing the shop.
Every astrology marketplace eventually discovers the same business: the remedy. A consultation is thirty minutes of revenue; a blue sapphire is a thousand dollars of it. It does not take long before the reading bends toward the stone.
We sell remedies too. A yantra that has actually been energised, a mala from a known maker, a stone with a certificate that means something — these are worth sourcing properly, and a household that trusts us would rather get them from us than gamble on a listing. So the shop exists. The question is how to keep it from corrupting the prescription.
Our answer is two doors, and a rule underneath them.
The rule: a consultant’s pay never depends on what a client buys. Sittings pay a fixed rate or a fixed share. Product sales pay the consultant nothing — not a commission, not a bonus, not a “quality incentive”. We keep track of which prescriptions were followed, because that tells us who prescribes well; it never touches a payout.
The doors: when your Acharya prescribes something you need to acquire, the app shows you their pick and then offers three ways forward. Buy it from Grahrishi, with the certification and provenance that is the reason to buy from us at all. Get it on Amazon — the same item, from the open market, tomorrow if you’re in the US. Or I already have this.
The second door is the point. An app that only offers one door is telling you something about its incentives. An app that sends you to Amazon with a shrug is telling you the prescription was the product, not the sale. Every door is recorded the same way — prescribed, acquired, kept — so the follow-up on the remedy does not depend on where you got it.
The rule is what makes the doors honest. The doors are what let you see the rule.